TetraQ is an experienced commercial and regulatory compliant preclinical contract research organisation embedded in a university level research centre. TetraQ's broad range of high quality integrated preclinical testing services and R&D services backed up by in-depth technical-scientific expertise and experience in drug development and translational research sets it apart from so many other CROs.
TetraQ has successfully conducted preclinical drug development projects with industry partners for many years. These projects address different therapeutic areas, different methods and techniques and can range from lead identification, target identification, researching the mechanism of action, to preclinical testing in terms of efficacy and safety. For more information, visit the section on Collaborative Research and Development.
Professor Maree Smith elected 2011 Fellow of the Australian Academy of Technological Sciences and Engineering
Read More
Fraunhofer ITEM and TetraQ announce they offer a collaborative drug development environment to the biopharmaceutical industry
Read More
TetraQ provides bioanalytical support for academic projects at attractive academic rates.
Read More
Our NATA ISO 17025 (R&D) accreditation and GLP recognition allows our ADME, bioanalytical and Toxicology work to be accepted internationally for regulatory review.
QUICK LINKS